Accelerating Transformation of Life Science, Pharma and Biotech R&D with Emerging Technology

Discovery and development of medicines is resource intensive and extremely costly, taking over 10 years on average, with an estimated spend of $2.6 billion to bring a new drug to market. Recent reports suggest 70% of Pharma companies anticipate that smart technologies will positively enhance early discovery, R&D and quality operations, improving overall lab efficiency, productivity and accelerating time-to-market.

Diminishing returns from R&D investments, increasing costs and pressure to diversify product pipelines is  forcing Pharma and Biotech organizations to evolve and embrace the next generation of data-centric,  technology-driven, smart connected labs of the future.

However, a combination of strategy, vision, infrastructure, mindset and talent is a prerequisite to drive these types of results and ensure the successful integration and implementation of digitally optimized, connected smart labs of the future.

Join technology, service and solution providers at the Smart Labs Automation and Technology Summit on 23 May 2023 in Boston, USA to collaboratively share strategies to facilitate the transition to smart connect labs.

View Event Information